Showing results (141-150 of 330) with videos related to
Sort By:
Pageof 33
Anticancer Research|December 31, 2024
Treatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular CarcinomaNobuaki Ishihara, Shohei Komatsu, Yoshihiko Yano, et al.Gut|November 9, 2016
Protein and glycomic plasma markers for early detection of adenoma and colon cancerJung-Hyun Rho, Jon J Ladd, Christopher I Li, et al.Journal of Gastroenterology and Hepatology|January 12, 2016
Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinomaAnthony W H Chan, Takshi Kumada, Hidenori Toyoda, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2020
Serum Levels of α-Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular CarcinomaDavid M Hughes, Sarah Berhane, C A Emily de Groot, et al.European Journal of Gastroenterology & Hepatology|June 27, 2025
Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosisKazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.Ultrasound in Medicine & Biology|January 8, 2021
A New Ultrasonographic "Fluttering Sign" for Hepatic HemangiomaNatsuko Kobayashi, Hiroko Iijima, Toshifumi Tada, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 26, 2018
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, et al.Liver Cancer|April 26, 2019
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter AnalysisAtsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji, et al.Eclinicalmedicine|September 8, 2023
Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysisAnand V Kulkarni, Harshvardhan Tevethia, Karan Kumar, et al.Cancers|February 13, 2019
Utility of FIB4-T as a Prognostic Factor for Hepatocellular CarcinomaKazuya Kariyama, Kazuhiro Nouso, Hidenori Toyoda, et al.Pageof 33